These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20178473)

  • 21. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
    Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A
    J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas.
    Zhang Y; Huang D; Yu G
    Acta Otolaryngol; 2005 Dec; 125(12):1345-50. PubMed ID: 16303685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma.
    Lo Muzio L; Staibano S; Pannone G; Mignogna MD; Mariggiò A; Salvatore G; Chieffi P; Tramontano D; De Rosa G; Altieri DC
    Exp Mol Pathol; 2001 Jun; 70(3):249-54. PubMed ID: 11418003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
    Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survivin gene expression in early-stage non-small cell lung cancer.
    Falleni M; Pellegrini C; Marchetti A; Oprandi B; Buttitta F; Barassi F; Santambrogio L; Coggi G; Bosari S
    J Pathol; 2003 Aug; 200(5):620-6. PubMed ID: 12898598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
    Mainou-Fowler T; Overman LM; Dignum H; Wood K; Crosier S; Angus B; Proctor SJ; Anderson JJ
    Int J Oncol; 2008 Jan; 32(1):59-68. PubMed ID: 18097543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No prognostic impact of survivin expression in glioblastoma.
    Preusser M; Gelpi E; Matej R; Marosi C; Dieckmann K; Rössler K; Budka H; Hainfellner JA
    Acta Neuropathol; 2005 May; 109(5):534-8. PubMed ID: 15843906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression.
    Maurer TA; Christian KV; Kerschmann RL; Berzin B; Palefsky JM; Payne D; Tyring SK; Berger TG
    Arch Dermatol; 1997 May; 133(5):577-83. PubMed ID: 9158410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders.
    Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Green JA
    Am J Vet Res; 2008 Aug; 69(8):1073-8. PubMed ID: 18672973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma.
    Weinman EC; Roche PC; Kasperbauer JL; Cha SS; Sargent DJ; Cheville J; Murphy LM; Chen L; Wettstein PJ; Gostout B; Ferrone S; Strome SE
    Cancer; 2003 May; 97(9):2203-11. PubMed ID: 12712472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line.
    Grossman D; McNiff JM; Li F; Altieri DC
    Lab Invest; 1999 Sep; 79(9):1121-6. PubMed ID: 10496530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between survivin expression and locoregional control in cervical squamous cell carcinomas treated with radiation therapy.
    Suzuki Y; Oka K; Yoshida D; Shirai K; Ohno T; Kato S; Tsujii H; Nakano T
    Gynecol Oncol; 2007 Mar; 104(3):642-6. PubMed ID: 17141299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maspin expression in normal skin and usual cutaneous carcinomas.
    Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
    Virchows Arch; 2002 Dec; 441(6):551-8. PubMed ID: 12461611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of p63 normal canine skin and primary cutaneous glandular carcinomas.
    Saraiva AL; Gärtner F; Pires MA
    Vet J; 2008 Jul; 177(1):136-40. PubMed ID: 17804265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells.
    Chen XM; Luan XY; Lei DP; Ma XJ; Liu XX; Liu J; Pan XL
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):168-75. PubMed ID: 18391576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
    Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
    Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenesis in squamous cell carcinomas of canine skin: an immunohistochemical and quantitative analysis.
    Maiolino P; Papparella S; Restucci B; De Vico G
    J Comp Pathol; 2001; 125(2-3):117-21. PubMed ID: 11578126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma.
    Ikeguchi M; Kaibara N
    Br J Cancer; 2002 Oct; 87(8):883-7. PubMed ID: 12373603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.